Company Filing History:
Years Active: 2023
Title: Céline Monnet: Innovator in Fc Mutant Technology
Introduction
Céline Monnet is a notable inventor based in Lambersart, France. He has made significant contributions to the field of biotechnology, particularly in the development of Fc mutants with improved functional activity. His work has implications for therapeutic applications, enhancing the efficacy of treatments that rely on Fc fragment interactions.
Latest Patents
Céline Monnet holds a patent for "Fc mutants with improved functional activity." This invention relates to a variant of a parent polypeptide comprising an Fc fragment. The variant exhibits an increased affinity for specific Fc fragment receptors, including FcγRIIIa (CD16a), FcγRIIa (CD32a), and FcγRIIb (CD32b). The patent details numerous mutations that enhance the functional activity of the Fc fragment, showcasing his innovative approach to protein engineering.
Career Highlights
Throughout his career, Céline Monnet has worked with prominent organizations, including Laboratoire Français Du Fractionnement Et Des Biotechnologies. His experience in these institutions has allowed him to refine his expertise in biotechnological innovations and contribute to advancements in the field.
Collaborations
Céline Monnet has collaborated with notable professionals such as Philippe Mondon and Alexandre Fontayne. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Céline Monnet's contributions to the field of biotechnology, particularly through his patent on Fc mutants, highlight his role as an innovator. His work continues to influence therapeutic developments, showcasing the importance of innovation in science and technology.